首页> 外文期刊>Laboratory news >Science and the corporate agenda
【24h】

Science and the corporate agenda

机译:科学与公司议程

获取原文
获取原文并翻译 | 示例
       

摘要

For many years, medical researchers have highlighted the problems related to the involvement of the powerful pharmaceutical industry within scientific work. Evidence has been gathered demonstrating research bias, undeclared conflicts of interest, unfavourable results left unpublished, and a research agenda increasingly focussed on short-term economic gain at the expense of health benefits. As action is taken to try to deal with the problems within the medical field, further evidence - summarised in a recent report published by Scientists for Global Responsibility - shows that other sectors are experiencing similar difficulties.
机译:多年来,医学研究人员强调了与强大的制药业参与科学工作有关的问题。收集到的证据表明研究偏见,未声明的利益冲突,未发表的不利结果,并且研究议程越来越侧重于短期经济利益,却损害了健康利益。在采取行动尝试解决医学领域内的问题时,进一步的证据-全球责任科学家最近发表的一份报告总结了该证据-表明其他部门也遇到了类似的困难。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号